Seung Min Hahn

Dr. Seung Min Hahn

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2017 in Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
IHIn Kyung Hwang
In Kyung Hwang
SHSeung Min Hahn
Seung Min Hahn
HKHyo Sun Kim
Hyo Sun Kim
SKSang Kyum Kim
Sang Kyum Kim
HKHyo Song Kim
Hyo Song Kim
JHJung Woo Han
Jung Woo Han
Malignant peripheral nerve sheath tumors (MPNSTs) are a rare subtype of sarcoma that occur spontaneously or in association with neurofibromatosis type 1 (NF-1). This study aimed to clinically differentiate these types of MPNSTs. The study reviewed 95 patients diagnosed with and treated for MPNST at Yonsei University Health System, Seoul, Korea over a 27-year period. The clinical characteristics, prognostic factors, and treatment outcomes of sporadic MPNST (sMPNST) and NF-1 associated MPNST (NF-MPNST) cases were compared. Patients with NF-MPNST had a significantly lower median age (32 years vs. 45 years for sMPNST, p=0.012), significantly larger median tumor size (8.2 cm vs. 5.0 cm for sMPNST, p < 0.001), and significantly larger numbers of imaging studies and surgeries (p=0.004 and p < 0.001, respectively). The 10-year overall survival (OS) rate of the patients with MPNST was 52±6%. Among the patients with localized MPNST, patients with NF-MPNST had a significantly lower 10-year OS rate (45±11% vs. 60±8% for sMPNST, p=0.046). Univariate analysis revealed the resection margin, pathology grade, and metastasis to be significant factors affecting the OS (p=0.001, p=0.020, and p < 0.001, respectively). Multivariate analysis of the patients with localized MPNST identified R2 resection and G1 as significant prognostic factors for OS. NF-MPNST has different clinical features from sMPNST and requires more careful management. Further study will be needed to develop specific management plans for NF-MPNST.

15 July 2018 in Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
Chung-Min KangChung-Min Kang
Chung-Min Kang
SHSeung Min Hahn
Seung Min Hahn
HKHyo Sun Kim
Hyo Sun Kim
CLChuhl Joo Lyu
Chuhl Joo Lyu
JLJae-Ho Lee
Jae-Ho Lee
JHJung Woo Han
Jung Woo Han
Although studies regarding dental developmental disturbances after childhood cancer treatment have increased, they have many limitations. Studies analyzing the significance of independent clinical risk factors with regard to the dental health status are also rare. We aimed to investigate the risk factors for dental developmental disturbances, particularly severe disturbances, in childhood cancer survivors (CCS). Oral examinations and retrospective reviews of medical and panoramic radiographs were performed for 196 CCS (mean age, 15.6 years). Cancer type, age at diagnosis, treatment modality, type and accumulated dose of administered drugs, and dose and site of radiation were recorded. Dental developmental disturbances were diagnosed using panoramic radiographs and graded for severity according to the Modified Dental Defect Index (MDDI). Descriptive statistics and multivariate analyseswere performed to determine the association between dental abnormalities and clinical factors. In total, 109 CCS (55.6%) exhibited at least one dental anomaly, and the median value of MDDI was 2.5. Microdontia (30.6%) was the most prevalent anomaly, followed by tooth agenesis (20.4%), V-shaped roots (14.8%), and taurodontism (10.2%). Multivariate analysis revealed that a young age at diagnosis (≤ 3 years), a history of hematopoietic stem cell transplantation, the use of multiple classes of chemotherapeutic agents (≥ 4 classes), and the use of heavy metal agents were significant risk factors for severe dental disturbances. CCS with any of the above risk factors for severe developmental disturbances should be comprehensively followed up to minimize adverse consequences to their dental development and preserve their future dental health.

18 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SHSeung Min Hahn
Seung Min Hahn
SKSeung Kim
Seung Kim
KPKook In Park
Kook In Park
SHSeok Joo Han
Seok Joo Han
HKHong Koh
Hong Koh
The progression of hepatic fibrosis may result in decompensated hepatic failure with cirrhosis, liver related events (LRE) such as ascites, variceal bleeding, and death after successful and timely Kasai hepatoportoenterostomy (HPE) in biliary atresia. The aim of this study is to suggest clinical benefit of the liver stiffness measurement (LSM) using transient elastography at 3 months after the Kasai operation to predict LRE. Between January 2007 and December 2011, 69 eligible biliary atresia patients who underwent Kasai HPE and performed transient elastography before and 3 months after HPE were included. The occurrences of LRE were analyzed for all patients. All patients were divided into 2 groups (with and without LRE) for comparison. Multivariate analysis was used to detect the independent risk factors of LRE. The area under the receiver operation characteristics curve (AUROC) was used to establish the LSM optimal cutoff value of 3 months after Kasai operation in predicting LRE. LSM value, aminotransferase, albumin, bilirubin, and PT-INR significantly differed among the two groups. Multivariate analysis demonstrated LSM value as the most powerful independent factor of the development of LRE. The cut-off value of 19.9 kPa was calculated to be optimal for predicting LRE development with total sensitivity and specificity of 1.804. AUROC resulted in 0.943, with sensitivity of 85.3% and specificity of 95.2%. The LSM value of 3 months after Kasai HPE can be a useful predictor of LRE development.

29 October 2015 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
JLJi Hwan Lee
Ji Hwan Lee
JHJung Woo Han
Jung Woo Han
SHSeung Min Hahn
Seung Min Hahn
CLChuhl Joo Lyu
Chuhl Joo Lyu
DKDong Joon Kim
Dong Joon Kim
SLSung Chul Lee
Sung Chul Lee

13 May 2015 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
JHJung Woo Han
Jung Woo Han
HKHyo Sun Kim
Hyo Sun Kim
SHSeung Min Hahn
Seung Min Hahn
SJSong Lee Jin
Song Lee Jin
YSYoon Jung Shin
Yoon Jung Shin
CLChuhl Joo Lyu
Chuhl Joo Lyu

1 January 2016 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
SJSong Lee Jin
Song Lee Jin
SHSeung Min Hahn
Seung Min Hahn
HKHyo Sun Kim
Hyo Sun Kim
YSYoon Jung Shin
Yoon Jung Shin
SKSun Hee Kim
Sun Hee Kim
JHJung Woo Han
Jung Woo Han
Jin SL, et al. Yonsei Med J. 2016 May;57(3):572-579. http://dx.doi.org/10.3349/ymj.2016.57.3.572